• Academy
    • Find lectures & contributors
    • Webinars on-demand
    • Online courses
    • 89th EAS Congress, Helsinki 2021
  • Publications
  • Become an EAS member
    Sign in
    • Academy
      • Find lectures & contributors
      • Webinars on-demand
      • Online courses
      • 89th EAS Congress, Helsinki 2021
    • Publications
    • Become an EAS member
    • Sign in

    Origin/Event: Publications

    Prevention and Treatment of Atherosclerosis – Improving State-of-the-Art Management and Search for Novel Targets

    Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease European Atherosclerosis Society/European Society of Vascular Medicine Joint Statement

    2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

    Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

    Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

    Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force

    Taking action: European Atherosclerosis Society targets the United Nations Sustainable Development Goals 2030 agenda to fight atherosclerotic cardiovascular disease in Europe

    Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

    Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM

    Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement

    Load More

    Recent Posts

    • ASCVD and Lp(a) assessment survey among clinicians
    • EAS Annual Members’ General Assembly
    • Gene-based therapies. The next generation of Atherosclerosis treatment
    • EAS Lipid Clinic Network

    Recent Comments

      © 2022 - EAS Digital

      Report

      Harassment or bullying behavior
      Contains mature or sensitive content
      Contains misleading or false information
      Contains abusive or derogatory content
      Contains spam, fake content or potential malware

      Block Member?

      Please confirm you want to block this member.

      You will no longer be able to:

      • See blocked member's posts
      • Mention this member in posts
      • Invite this member to groups
      • Message this member
      • Add this member as a connection

      Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

      Report

      You have already reported this